NCT03660527 is a clinical trial of Not refered in Nutrition Status of Chinese Residents, sponsored by Centers for Disease Control and Prevention, China.

Who is sponsoring NCT03660527?

NCT03660527 is sponsored by Centers for Disease Control and Prevention, China.

What drugs are being tested in NCT03660527?

Interventions in NCT03660527: Not refered.

What condition does NCT03660527 study?

NCT03660527 studies Nutrition Status of Chinese Residents.

Is NCT03660527 still recruiting?

NCT03660527 is currently completed. Last updated 6 September 2018.

Last reviewed 2018-09-06 · How we verify

NCT03660527

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nutritional Status of Chinese Residents

Completed Last updated 6 September 2018

What this trial tests

trial testing Not refered in Nutrition Status of Chinese Residents in 41,420 participants. Completed in 30 December 2017.

Timeline

1 January 2010

Primary endpoint
30 December 2013

30 December 2017

Quick facts

Lead sponsor	Centers for Disease Control and Prevention, China
Status	Completed
Study type	OBSERVATIONAL
Enrollment	41,420
Start date	1 January 2010
Primary completion	30 December 2013
Estimated completion	30 December 2017

Drugs / interventions tested

Not refered

Conditions studied

Nutrition Status of Chinese Residents — all drugs for Nutrition Status of Chinese Residents →

Sponsor

Centers for Disease Control and Prevention, China — full company profile →

Who can join

6 and older, any sex, with Nutrition Status of Chinese Residents. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, we analyzed the nutritional status of Chinese residents aged above 6y. The indicators such as the hemoglobin, vitamin D, vitamin A and TG, TC and HDLC were also included. Related risk factors (such as age, region type, ethnicity, bodyweight, height, education, season, smoke habit, etc).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centers for Disease Control and Prevention, China trials

Trials by the same sponsor.

NCT05298800 — Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 · Phase 4 · unknown
NCT04614597 — A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China · completed
NCT05087277 — Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain · unknown
NCT05072496 — Study on Antibody Persistence and Immune Memory of Inactivated COVID-19 Vaccine · completed
NCT03597919 — A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China. · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03660527 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centers for Disease Control and Prevention, China
Last refreshed: 6 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03660527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing